Adalimumab therapy is associated with increased faecal short chain fatty acids in hidradenitis suppurativa

Altered gut microbiota composition has been observed in individuals with hidradenitis suppurutiva (HS) and many other inflammatory diseases, including obesity, type 1 and type 2 diabetes. Here, we addressed whether adalimumab, a systemic anti‐inflammatory therapy, may impact the microbiota biochemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatian, Artiene, Bordbar, Sara, Sarkissian, Samuel Der, Woods, Jane A., Cains, Geoffrey D., Chong, Chun Wie, Mariño, Eliana, Frew, John W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087920/
https://www.ncbi.nlm.nih.gov/pubmed/36054650
http://dx.doi.org/10.1111/exd.14665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087920/
https://www.ncbi.nlm.nih.gov/pubmed/36054650
http://dx.doi.org/10.1111/exd.14665

Ejemplares similares